|
TRIM4 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.29265520299305E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.71502869870255E-12 |
| Normal-vs-Stage2 |
2.586400E-02 |
| Normal-vs-Stage3 |
2.4491519923231E-12 |
| Normal-vs-Stage4 |
1.99330552064225E-11 |
| Stage1-vs-Stage2 |
3.207900E-02 |
| Stage1-vs-Stage3 |
1.626030E-02 |
| Stage1-vs-Stage4 |
1.158010E-02 |
| Stage2-vs-Stage3 |
1.641780E-03 |
| Stage2-vs-Stage4 |
7.971400E-04 |
| Stage3-vs-Stage4 |
5.786200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.00315328161105E-13 |
| Normal-vs-AfricanAmerican |
6.395000E-03 |
| Normal-vs-Asian |
5.85139999786932E-08 |
| Caucasian-vs-AfricanAmerican |
3.810200E-02 |
| Caucasian-vs-Asian |
6.355600E-01 |
| AfricanAmerican-vs-Asian |
1.093570E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.1412984980459E-11 |
| Normal-vs-Female |
4.59580151712657E-11 |
| Male-vs-Female |
1.997190E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.05969702299558E-11 |
| Normal-vs-Age(41-60Yrs) |
4.73160000069583E-09 |
| Normal-vs-Age(61-80Yrs) |
1.49449996822426E-09 |
| Normal-vs-Age(81-100Yrs) |
2.3105999999995E-05 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.953600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.550400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.162830E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.785170E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.189600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.265800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.782770E-03 |
| Classical-VS-Follicular |
1.579570E-01 |
| Classical-VS-Other |
8.921000E-01 |
| Classical-VS-Normal |
6.77036204876913E-12 |
| Tall-VS-Follicular |
5.155100E-04 |
| Tall-VS-Other |
3.276000E-01 |
| Tall-VS-Normal |
2.24176233132312E-12 |
| Follicular-VS-Other |
7.390800E-01 |
| Follicular-VS-Normal |
7.70469999999968E-05 |
| Other-VS-Normal |
1.627590E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.07109998437727E-09 |
| Normal-vs-N1 |
1.84063875252605E-12 |
| N0-vs-N1 |
2.860300E-03 |
|
|
